Evotec Results Presentation Deck

in € m¹) evotec Revenues from contracts with customers Gross margin ● R&D expenses • SG&A expenses Impairment of intangible assets Impairment of goodwill • Other op. income (expenses), net Operating result Adjusted Group EBITDA²) Capacity build-up temporarily affects margin Condensed income statement Q2 2021 - Evotec SE and subsidiaries Net income PAGE 15 Q2 2021 138.2 18.5% (17.0) (25.2) (0.7) 18.8 1.5 15.1 60.0 Q2 2020 111.6 17.7% (14.7) (19.3) 17.0 2.8 17.3 (9.8) • Base revenues accelerated in Q2 versus Q1 2021 across all business lines while fx headwinds • R&D investments higher - as planned • SG&A reflects further dynamic growth and strategic projects • As a result EBITDA slightly below previous year level EVO equity: Net Income benefits from 2nd fair value adjustment in 2021 of Exscientia investment ¹) Differences may occur due to rounding 2) Before contingent considerations, income from bargain purchase and excl. impairments on goodwill, other intangible and tangible assets as well as the total non-operating result

View entire presentation